郑州大学附属儿童医院/河南省儿童医院郑州儿童医院南院区呼吸科,河南 450000
Received:16 February 2025,
Revised:2025-04-15,
Accepted:28 April 2025,
Published:28 March 2026
移动端阅览
熊蕾蕾,张向峰,张志英等.外周血单个核细胞IL-33、IFN-γ与儿童哮喘气道炎症、症状控制水平的相关性及意义[J].重庆医科大学学报,2026,51(03):419-425.
Xiong Leilei,Zhang Xiangfeng,Zhang Zhiying,et al.Correlation and significance of interleukin-33 and interferon gamma in peripheral blood mononuclear cells with airway inflammation and symptom control in children with asthma[J].Journal of Chongqing Medical University,2026,51(03):419-425.
熊蕾蕾,张向峰,张志英等.外周血单个核细胞IL-33、IFN-γ与儿童哮喘气道炎症、症状控制水平的相关性及意义[J].重庆医科大学学报,2026,51(03):419-425. DOI: 10.13406/j.cnki.cyxb.003885.
Xiong Leilei,Zhang Xiangfeng,Zhang Zhiying,et al.Correlation and significance of interleukin-33 and interferon gamma in peripheral blood mononuclear cells with airway inflammation and symptom control in children with asthma[J].Journal of Chongqing Medical University,2026,51(03):419-425. DOI: 10.13406/j.cnki.cyxb.003885.
目的
2
分析外周血单个核细胞白细胞介素-33(interleukin-33,IL-33)、干扰素-γ(interferon-gamma,IFN-γ)与儿童哮喘气道炎症、症状控制水平的相关性及意义。
方法
2
选取2022年11月至2024年12月郑州大学附属儿童医院/河南省儿童医院郑州儿童医院收治的105例哮喘患儿作为哮喘组,选取同期健康体检儿童105例作为对照组。将哮喘组患儿根据症状控制水平分为控制组、未控制组。统计2组外周血单个核细胞IL-33、IFN-γ、气道炎症[嗜酸性粒细胞百分比(eosinophil percentage,EOS%)、呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)、免疫球蛋白E(immunoglobulin e,IgE)],分析外周血单个核细胞IL-33、IFN-γ与气道炎症、症状控制水平的相关性,并分析外周血单个核细胞IL-33、IFN-γ对哮喘症状控制水平的效应,受试者工作特征(receiver operating characteristic,ROC)曲线分析外周血单个核细胞IL-33联合IFN-γ预测哮喘控制水平的作用的影响及预测价值。
结果
2
哮喘组IL-33、EOS%、FeNO、IgE[(36.19±4.20) ng/L、(18.65±0.91)%、(45.90±2.63) ppb、(275.68±20.39) IU/mL]高于对照组[(7.55±2.43) ng/L、(0.89±0.28)%、(5.77±1.94) ppb、(54.92±17.45) IU/mL],IFN-γ(52.72±16.18) ng/L低于对照组(90.15±20.77) ng/L(
t
=25.607、30.758、32.181、35.986、9.770,均
P<
0.05);Pearson相关性分析显示,IL-33与EOS%、FeNO、IgE呈正相关(
r
=0.720、0.749、0.722,均
P
<
0.05),IFN-γ与EOS%、FeNO、IgE呈负相关(
r
=-0.739、-0.703、-0.767,均
P
<
0.05);未控制组IL-33(48.93±15.87) ng/L高于控制组(20.47±6.56) ng/L,IFN-γ(41.66±12.40) ng/L低于控制组(66.37±18.25) ng/L(
t
=11.515、8.234,均
P
<
0.05);IL-33(
OR
=1.398,95%CI=1.166~1.675)、IFN-γ(
OR
=0.421,95%CI=0.243~0.728)是症状控制水平的独立相关影响因素(
P
<
0.05);IL-33、IFN-γ与哮喘症状控制水平呈线性关系,其中IL-33为负向线性关系,IFN-γ呈正向线性关系;ROC分析显示,IL-33、IFN-γ预测哮喘控制水平的AUC分别为0.745(95%CI=0.651~0.825)、0.766(95%CI=0.673~0.843);以R00为参照,R01、R10、R11亚组患儿哮喘控制不良的风险值
OR
(95%CI)分别为1.293(95%CI=1.056~1.582)、1.406(95%CI=1.133~1.744)、7.472(95%CI=5.062~11.029)(
P
<
0.05);IL-33高表达+IFN-γ低表达对哮喘控制水平具有正相加交互作用,二者交互作用所占的比例为77.26%;IL-33联合IFN-γ预测哮喘控制水平的AUC为0.883(95%CI=0.806~0.938),敏感度为82.98%,特异度为81.03%(
P
<
0.001),大于IL-33、IFN-γ(
Z
=2.409、2.030,
P
=0.016、0.042)。
结论
2
外周血单个核细胞IL-33、IFN-γ水平与哮喘气道炎症反应、症状控制水平密切相关,为临床早期预测症状控制水平、针对性制定相应干预方案提供参考依据。
Objective
2
To investigate the correlation and significance of interleukin-33(IL-33) and interferon gamma(IFN-γ) in peripheral blood mononuclear cells with airway inflammation and symptom control in children with asthma.
Methods
2
A total of 105 children with asthma who were admitted to Children’s Hospital Affiliated to Zhengzhou University/Zhengzhou Children’s Hospital of Henan Children’s Hospital from November 2022 to December 2024 were enrolled as asthma group,and 105 children who underwent physical examination during the same period of time were enrolled as control group. According to the level of symptom control,the asthma group was further divided into controlled group and uncontrolled group. The two groups were analyzed in terms of the levels of IL-33 and IFN-γ in peripheral blood mononuclear cells and airway inflammation(eosinophil percentage[EOS%],fractional exhaled nitric oxide[FeNO],and immunoglobulin E [IgE]),and the correlation of IL-33 and IFN-γ in peripheral blood mononuclear cells with airway inflammation and symptom control was analyzed,as well as the effect of IL-33 and IFN-γ on the level of symptom control in asthma. The ROC curve analysis was used to investigate the value of IL-33 combined with IFN-γ in predicting the level of asthma control.
Results
2
Compared with the control group,the asthma group had significantly higher levels of IL-33[(36.19±4.20) ng/L vs. (7.55±2.43) ng/L,
t
=25.607,
P
<
0.05],EOS%[(18.65±0.91)% vs. (0.89±0.28)%,
t
=30.758,
P
<
0.05],FeNO[(45.90±2.63) ppb vs. (5.77±1.94) ppb,
t
=32.181,
P
<
0.05],and IgE[(275.68±20.39) IU/mL vs. (54.92±17.45) IU/mL,
t
=35.986,
P
<
0.05] and a significantly lower level of IFN-d[(52.72±16.18) ng/L vs. (90.15±20.77) ng/L,
t
=9.770,all
P
<
0.05]. The Pearson correlation analysis showed that IL-33 was positively correlated with EOS%,FeNO,and IgE(
r
=0.720,0.749,and 0.722,all
P
<
0.05),while IFN-γ was negatively correlated with EOS%,FeNO,and
IgE(
r
=-0.739,-0.703,and -0.767,all
P
<
0.05). Compared with the controlled group,the uncontrolled group had a significantly higher level of IL-33[(48.93±15.87) ng/L vs. (20.47±6.56) ng/L,
t
=11.515,
P
<
0.05] and a significantly lower level of IFN-γ[(41.66±12.40) ng/L vs. (66.37±18.25) ng/L,
t
=8.234,all
P
<
0.05]. IL-33(odds ratio[
OR
]=1.398,95%CI=1.166-1.675,
P
<
0.05) and IFN-γ(
OR
=0.421,95%CI=0.243-0.728,
P
<
0.05) were independent influencing factors for the level of symptom control,and both IL-33 and IFN-γ had a linear relationship with the level of symptom control in asthma,among which IL-33 exhibited a negative linear relationship and IFN-γ exhibited a positive linear relationship. The ROC curve analysis showed that IL-33 and IFN-γ had an AUC of were 0.745(95%CI=0.651-0.825) and 0.766 (95%CI=0.673-0.843),respectively,in predicting the level of asthma control. With the R00 subgroup as the reference,the R01,R10,and R11 subgroups had an OR value of 1.293(95%CI=1.056-1.582,
P
<
0.05),1.406(95%CI=1.133-1.744,
P
<
0.05),and 7.472 (95%CI=5.062-11.029,
P
<
0.05),respectively,for poor asthma control. The high expression of IL-33 and the low expression of IFN-γ had a positive additive interaction on the level of asthma control,with a proportion of 77.26% for the interaction between the two indicators. IL-33 combined with IFN-γ had an AUC of 0.883(95%CI=0.806-0.938,
P
<
0.001) in predicting the level of asthma control,with a sensitivity of 82.98% and a specificity of 81.03%,which were greater than those of IL-33 and IFN-γ(
Z
=2.409 and 2.030,
P
=0.016 and 0.042).
Conclusion
2
The levels of IL-33 and IFN-γ in peripheral blood mononuclear cells are closely associated with airway inflammation and symptom control in asthma,which provides a reference for predicting the level of symptom control in the early stage and developing targeted intervention regimens.
Savin IA , Zenkova MA , Sen’kova AV . Bronchial asthma,airway remodeling and lung fibrosis as successive steps of one process [J ] . Int J Mol Sci , 2023 , 24 ( 22 ): 16042 .
Barosova R , Baranovicova E , Hanusrichterova J , et al . Metabolomics in animal models of bronchial asthma and its translational importance for clinics [J ] . Int J Mol Sci , 2023 , 25 ( 1 ): 459 .
Kleniewska P , Pawliczak R . Can probiotics be used in the prevention and treatment of bronchial asthma? [J ] . Pharmacol Rep , 2024 , 76 ( 4 ): 740 - 753 .
齐莎莎 , 张国伟 , 孟凡威 , 等 . lncRNA XIST和miR-124在支气管哮喘患儿外周血单个核细胞中表达关系研究 [J ] . 安徽医学 , 2022 , 43 ( 8 ): 901 - 905 .
Qi SS , Zhang GW , Meng FW , et al . Relationship between expression of lncRNA XIST and miR-124 in peripheral blood mononuclear cells of children with bronchial asthma [J ] . Anhui Med J , 2022 , 43 ( 8 ): 901 - 905 .
Curren B , Ahmed T , Howard DR , et al . IL-33-induced neutrophilic inflammation and NETosis underlie rhinovirus-triggered exacerbations of asthma [J ] . Mucosal Immunol , 2023 , 16 ( 5 ): 671 - 684 .
Badi YE , Salcman B , Taylor A , et al . IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma [J ] . Allergy , 2023 , 78 ( 1 ): 156 - 167 .
Ma DH , Muñoz X , Ojanguren I , et al . Increased TGFβ1,VEGF and IFN-γ in the sputum of severe asthma patients with bronchiectasis [J ] . Arch Bronconeumol , 2024 , 60 ( 11 ): 682 - 689 .
Kim YC , Song WJ . Neuro-immune interactions and IFN-γ in post-infectious cough [J ] . Allergy Asthma Immunol Res , 2022 , 14 ( 6 ): 581 - 584 .
中华医学会儿科学分会呼吸学组 , 《中华儿科杂志》编辑委员会 . 儿童支气管哮喘诊断与防治指南(2016年版) [J ] . 中华儿科杂志 , 2016 , 54 ( 3 ): 167 - 181 .
Respiratory Group of the Chinese Medical Association , Editorial Committee of the Chinese Journal of Pediatrics . Guidelines for Diagnosis and Prevention of Childhood Bronchial Asthma(2016 Edition) [J ] . Chinese Journal of Pediatrics , 2016 , 54 ( 3 ): 167 - 181 .
Lin ZH , Yuan L , Zhang CF , et al . Association of bronchial asthma with lung cancer:a systematic review and meta-analysis [J ] . Iran J Allergy Asthma Immunol , 2024 , 23 ( 4 ): 347 - 356 .
Yan Q , Zhang XX , Xie Y , et al . Bronchial epithelial transcriptomics and experimental validation reveal asthma severity-related neutrophilc signatures and potential treatments [J ] . Commun Biol , 2024 , 7 ( 1 ): 181 .
Kubysheva NI , Eliseeva TI , Postnikova LB , et al . Cognitive impairments in patients with bronchial asthma [J ] . Bull Exp Biol Med , 2023 , 174 ( 5 ): 585 - 588 .
Sverrild A , Cerps S , Nieto-Fontarigo JJ , et al . Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma [J ] . Allergy , 2024 , 79 ( 3 ): 656 - 666 .
Daneshvar-Ghahfarokhi S , Mohammadi-Shahrokhi V , Rahnama A , et al . Teucrium polium extract alleviates pathological features of asthma via lL-12 and IFN-γ modulation in murine OVA-induced allergic asthma [J ] . Iran J Allergy Asthma Immunol , 2023 , 22 ( 4 ): 327 - 336 .
Mehrabi Nasab E , Hassanzadeh Makoei R , Aghajani H , et al . IL-33/ST2 pathway as upper-hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure [J ] . ESC Heart Fail , 2022 , 9 ( 6 ): 3785 - 3790 .
Gaurav R , Poole JA . Interleukin(IL)-33 immunobiology in asthma and airway inflammatory diseases [J ] . J Asthma , 2022 , 59 ( 12 ): 2530 - 2538 .
England E , Rees DG , Scott IC , et al . Tozorakimab(MEDI3506):an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction [J ] . Sci Rep , 2023 , 13 ( 1 ): 9825 .
Nozari P , Mokhtari P , Nemati M , et al . Investigation of the effect of IFN-γ/TNF-α-treated mesenchymal stem cells on Th9- and Treg cell-related parameters in a mouse model of ovalbumin-induced allergic asthma [J ] . Immunopharmacol Immunotoxicol , 2022 , 44 ( 5 ): 773 - 785 .
Deng Z , Ding WB , Li FY , et al . Pulmonary IFN-γ causes lymphocytic inflammation and cough hypersensitivity by increasing the number of IFN-γ-secreting T lymphocytes [J ] . Allergy Asthma Immunol Res , 2022 , 14 ( 6 ): 653 - 673 .
Fagundes BO , de-Sousa TR , Victor JR . Gamma-delta(γδ) T cell-derived cytokines(IL-4,IL-17,IFN-γ and IL-10) and their possible implications for atopic dermatitis development [J ] . Int J Dermatol , 2023 , 62 ( 4 ): 443 - 448 .
李莹 , 姚军丽 , 赵娜 . 宣白承气汤联合布地奈德雾化治疗急性支气管哮喘的疗效及对肺功能、血清IL-4、IFN-γ、CRP的影响 [J ] . 辽宁中医杂志 , 2025 , 52 ( 1 ): 94 - 97 .
Li Y , Yao JL , Zhao N . The efficacy of Xuanbai Chengqi Tang combined with budesonide nebulization in the treatment of acute bronchial asthma and its effects on lung function,serum IL-4,IFN-γ,and CRP [J ] . Liaoning Journal of Traditional Chinese Medicine , 2025 , 52 ( 1 ): 94 - 97 .
胡译文 , 苏卫华 , 赵卉 . 2型固有淋巴细胞与支气管哮喘 [J ] . 临床与病理杂志 , 2024 , 44 ( 4 ): 603 - 611 .
Hu YW , Su WH , Zhao H . Type 2 inherent lymphocytes and bronchial asthma [J ] . J Clin Pathol Sci , 2024 , 44 ( 4 ): 603 - 611 .
张秋实 , 黄 丰 , 童晓云 , 等 . 五宝胶囊通过调节Ⅱ型固有淋巴细胞上下游细胞因子抑制哮喘模型小鼠气道炎症的研究 [J ] . 中国药房 , 2023 , 34 ( 2 ): 156 - 160 .
Zhang QS , Huang F , Tong XY , et al . Study on inhibitory effects of Wubao capsule on airway inflammation in asthmatic model mice by regulating the upstream and downstream cytokines of type Ⅱ innate lymphoid cells [J ] . China Pharm , 2023 , 34 ( 2 ): 156 - 160 .
Mileva S , Ivanova-Todorova E , Tumagelova-Yuzeir K , et al . Periostin and IFN-γ levels in serum and nasopharyngeal aspirate in infants with viral-induced wheezing-2 year follow-up [J ] . Turk J Pediatr , 2022 , 64 ( 6 ): 1021 - 1030 .
田金娜 , 陈 迪 , 李建保 , 等 . 丹龙定喘汤对哮喘小鼠肺组织HMGB1、α-SMA、IL-4、IFN-γ、TGF-β1表达的影响 [J ] . 中成药 , 2021 , 43 ( 1 ): 195 - 199 .
Tian JN , Chen D , Li JB , et al . Effect of danlong Dingchuan decoction on the expression of HMGB1,α-SMA,IL-4,IFN-γ and TGF-β1 in lung tissue of asthmatic mice [J ] . Chin Tradit Pat Med , 2021 , 43 ( 1 ): 195 - 199 .
0
Views
1
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
